id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-340666-zl9pp2h3	Reifer, Josh	SARS-CoV-2 IgG antibody responses in New York City	2020-07-21		.txt	text/plain	764	56	60	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a strain of coronavirus that causes coronavirus disease 2019 (Covid-19) and has been declared a global pandemic by the World Health Organization. Additionally, for a subset of patients, we report on the correlation between SARS-CoV-2 patient symptom severity and level of SARS-CoV-2 IgG antibody found in the patient sample. We next sought to evaluate whether semi-quantitative SARS-CoV-2 IgG antibody levels were correlated to severity of symptoms as measured by the SSI. Levels of SARS-CoV-2 IgG antibody are plotted against SSI in Figure 2A . A linear regression analysis of the data indicates that SARS-CoV-2 IgG antibody levels are positively correlated with SSI (p-value < 0.01). In addition, we tested 28,523 patient specimens for SARS-CoV-2 IgG antibody levels for whom we did not obtain a SSI. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease Antibody responses to SARS-CoV-2 in patients with COVID-19	./cache/cord-340666-zl9pp2h3.txt	./txt/cord-340666-zl9pp2h3.txt